GINKGO BIOWORKS HOLDINGS, INC. (DNA) Free cash flow 2019–2025
GINKGO BIOWORKS HOLDINGS, INC. (DNA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$178.7MFY2025 · since FY2019: -$66.9M → -$178.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$178.7M | +53.2% |
| FY2024 | -$382.1M | -13.6% |
| FY2023 | -$336.3M | -10.5% |
| FY2022 | -$304.5M | +1.9% |
| FY2021 | -$310.3M | -60.3% |
| FY2020 | -$193.7M | -189.5% |
| FY2019 | -$66.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice